In-silico designing of NKK: A better ligand than Aciclovir against Herpes Simplex Virus
Main Article Content
Abstract
Aciclovir is the best dr thymidine kinase made by the HSV. In the current study we have successfully designed a drug candidate “NKK”, which is far more efficient than aciclovir in terms of binding energy and physiochemical properties again used softwares viz. Autodock 4.0, FireDock and Hex dock in order to demonstrate that “NKK” is a better ligand than aciclovir with respect to aforesaid properties.
Article Details
How to Cite
1.
. N, Jeswara K, Kumari A, Singh K. In-silico designing of NKK: A better ligand than Aciclovir against Herpes Simplex Virus. IJPBR [Internet]. 31Mar.2015 [cited 17May2025];3(01):48-5. Available from: https://ijpbr.in/index.php/IJPBR/article/view/934
Section
Table of Content
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.